pipette
ENEnglish

NPM1::ALK fusion-derived circular RNAs drive aggressiveness in ALK-positive anaplastic large cell lymphoma

L. BABIN, L. Colras, S. Dailhau, S. Fuchs, S. Pyronnet, L. Lamant, F. Meggetto

Preprint

En palabras de los autores

Circular RNAs (circRNAs) derived from the NPM1::ALK fusion have been identified in ALK-positive anaplastic large cell lymphoma (ALK+ ALCL), but their functional contribution to disease progression remains poorly understood. Divergent RT-PCR and long-read Nanopore sequencing identified eight NPM1::ALK-derived circRNA variants across ALK(+) ALCL cell-lines, a CRISPR/Cas9-engineered model, and a patient-derived xenograft. The abundance of f-circA23N2 and f-circA26N3, recurrently detected, steadily increased in crizotinib-resistant cell models. Both, highly stable, were predominantly cytoplasmic. Their overexpression in SU-DHL-1 did not affect NPM1::ALK expression, cell proliferation, or cell-cycle, in the absence or presence of crizotinib. circRNA overexpression delayed subcutaneous tumor-growth without altering response to crizotinib. Xenograft analysis disclosed altered immune response pathways and changes in inflammatory and myeloid-recruiting cytokines. RNA-seq deconvolution identified remodeling of the myeloid compartment. Intravenous f-circA23N2 and f-circA26N3 shortened survival with systemic lymphoma dissemination. NPM1::ALK-derived circRNAs appear to be non-cell-autonomous modulators of cytokine signaling and myeloid remodeling contributing to lymphoma dissemination.

Resultado principalEl resumen no menciona limitaciones.

Apareció: viernes, 13 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.09.765349